- ►retina.it [PDF] MA Zarbin - Archives of ophthalmology, 2004 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 299 - Related articles - BL Direct - All 9 versions
- ►iovs.org JE Grunwald, TI Metelitsina, JC DuPont, GS … - Investigative ophthalmology & visual science, 2005 - ARVO METHODS. The study included 26 control eyes of 17 normal subjects and 163 eyes
with early AMD characteristics of 123 patients with AMD. The AMD study eyes were
divided into three groups according to increasing risk for development of ... Cited by 54 - Related articles - All 4 versions
- ►rheopherese-verslag.nl [PDF] R Klingel, C Fassbender, T Faßbender, B … - Transfusion and Apheresis Science, 2003 - Elsevier In the majority of age-related macular degeneration (AMD) patients the
therapeutic situation is very unsatisfactory, especially for patients with dry
AMD. Rheopheresis is a safe and effective modality of therapeutic apheresis ... Cited by 23 - Related articles - All 14 versions
AKC Lam, ST Chan, H Chan… - Optometry & Vision Science, 2003 - journals.lww.com Page 1. ORIGINAL ARTICLE The Effect of Age on Ocular Blood Supply Determined by
Pulsatile Ocular Blood Flow and Color Doppler Ultrasonography ... Cited by 22 - Related articles - BL Direct - All 4 versions
JS Pulido, D Sanders, R Klingel - Canadian Journal of Ophthalmology, 2005 - verisamd.com Jose S. Pulido,* MD, MS; Donald Sanders,† MD; Reinhard Klingel,‡ MD ...
ABSTRACT • RÉSUMÉ Background: Rheopheresis is being evaluated in a clinical
trial.The rationale and available results are presented. Methods: We ... Cited by 13 - Related articles - All 4 versions
J Pulido, D Sanders, JL Winters, R Klingel - Journal of Clinical Apheresis, 2005 - interscience.wiley.com The primary goals are to provide a comprehensive explanation of the potential
role of therapeutic apheresis in the treatment of Age-Related Macular
Degeneration (AMD). Initial clinical results with this technique and a ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►iovs.org HI Savage, JW Hendrix, DC Peterson, H … - Investigative ophthalmology & visual science, 2004 - ARVO METHODS. The study was a masked cross-sectional analysis. Seventy-seven diabetic
subjects, including 13 with mild or no retinopathy, 36 with moderate to severe
retinopathy, and 28 with proliferative diabetic retinopathy (PDR), ... Cited by 10 - Related articles - BL Direct - All 5 versions
- ►iovs.org TI Metelitsina, JE Grunwald, JC DuPont, GS … - Investigative Ophthalmology & Visual Science, 2008 - ARVO RESULTS. CNV developed in 28 eyes during the study. Baseline average foveolar
ChBVol and ChBFlow in these eyes were 24% (P < 0.0001) and 20% (P = 0.0007)
lower than that observed in the 165 eyes in which CNV did not develop. In ... Cited by 6 - Related articles - BL Direct - All 3 versions
SJ Chen, CY Cheng, AF Lee, FL Lee, WM Hsu … - Eye, 2004 - nature.com Purpose A previous study has shown that the pulsatile ocular blood flow (POBF)
in eyes with asymmetric age-related macular degeneration (AMD) differs. Whereas
eyes with drusen have higher POBF than contralateral eyes with disciform ... Cited by 5 - Related articles - All 4 versions
R Ehrlich, A Harris, NS Kheradiya, DM Winston … - Clinical Interventions in Aging, 2008 - pubmedcentral.nih.gov Age-related macular degeneration (AMD) is an ocular disease that causes damage
to the retinal macula, mostly in the elderly. Normal aging processes can lead to
structural and blood flow changes that can predispose patients to AMD, ... Cited by 5 - Related articles - All 6 versions
